About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Quantitative Prostate Cancer Contrast-enhanced Ultrasound

NCT02295449·3 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Olivier ROUVIERE, Professor
CONTACT
(0)4 72 11 09 51 [email protected]
Fanny CROS
CONTACT
(0)4 72 11 04 00 [email protected]

Lead

Hospices Civils de Lyon

Age

Any age

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Patient referred for prostate biopsy
Informed consent signed
Patient affiliated to the French Health Insurance

You may not be if

History of allergy to SonoVue®
History of myocardial infarction or angor pectoris
History of severe pulmonary arterial hypertension (\> 90 mm Hg)
History of previous treatment for prostate cancer (radiation therapy, brachytherapy, high-intensity focused ultrasound, etc…)
History of hormone therapy for prostate cancer

The record

StatusUnknown

PhaseNo phase

Taking part130

StartedJun 2015

UpdatedAug 31, 2018

Conditions

Prostate Cancer

Where3

CHU de Bordeaux - Hôpital Pellegrin - Service d'imagerie diagnostique et interventionnelle de l'adulte
Bordeaux, France
Hospices Civils de Lyon - Hopital Edouard Herriot
Lyon, France
Assistance Publique Hôpitaux de Paris - Hôpital Necker - Service de Radiologie adultes
Paris, France

Clareo Health | Quantitative Prostate Cancer Contrast-enhanced Ultrasound